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Summary
Kawasaki disease (KD) is an acute inflammatory 
vasculitis that occurs worldwide and 
disproportionately affects male children, most 
commonly between the ages of 6 months and 5 years. 
KD can present with only a few features and thus be 
difficult to diagnose, particularly in the youngest and 
oldest patients. We describe a 12-week-old Caucasian 
female infant who presented with rash and fever 
but no other features of KD, who developed giant 
coronary artery aneurysms. Considering how common 
is the presentation of a febrile infant with a rash, 
this case highlights the importance of considering KD 
early in the differential diagnosis for any infant with 
unexplained fever. Furthermore, it emphasises how 
echocardiography can help in the investigation of a 
febrile child with no clear source of infection.
BaCkground
Kawasaki disease (KD) is an acute inflammatory 
vasculitis that preferentially affects medium-sized 
arteries, particularly the coronary arteries.1 It 
is the leading cause of acquired cardiac disease 
in children in developed countries.2 It is more 
common in boys than girls, and in those of Asian 
ethnicity.3 The aetiology is unclear, but epidemi-
ological features such as the development of clus-
ters of disease has led to the suggestion that an 
infectious or agent or toxin may be implicated.4 
Most cases occur in children between 6 months 
and 5 years of age, but younger infants can also be 
affected.5 Although most patients recover fully, a 
proportion develops coronary artery aneurysms, 
which can result in severe acute and long-term 
sequelae. Aneurysms are more common in those 
patients in whom treatment is delayed or missed. 
Extremes of age have been identified as risk factors 
for coronary artery aneurysm development.6 
Coronary artery aneurysms develop in up to 
25% of untreated cases of KD with 2% to 3% of 
untreated cases dying due to coronary vasculitis.1 
Coronary artery dimensions are assessed in the UK 
by calculation of Z-score.7 8 A minority of patients 
develop giant coronary artery aneurysms; a recent 
study found an incidence of 2.6% in a cohort of 
American children with KD where giant aneu-
rysm was defined as a maximum Z-score ≥10. 
Giant coronary artery aneurysms are associated 
with 29% to 48% risk of adverse coronary artery 
events, including thrombosis, stenosis, myocardial 
infarction and death.9
The key features of Kawasaki disease are1:
 ► fever: duration of 5 days or more, plus
 ► conjunctivitis: bilateral, non-suppurative
 ► cervical lymphadenopathy (often single and 
large)
 ► rash: polymorphous
 ► changes to lips or oral mucosa
 ► changes to extremities
The diagnosis of complete KD requires fever 
plus four of the other above features to be 
present—although not necessarily at the same time. 
However, it is recognised that KD may present with 
fewer features and that these cases remain at risk 
of developing coronary artery aneurysms. Thus, 
patients with some of the above features—along 
with evidence of systemic inflammation (such as 
elevated C-reactive protein (CRP) or erythrocyte 
sedimentation rate, or leucocytosis)—may be diag-
nosed with incomplete KD. Echocardiography may 
show evidence of coronary vasculitis. If present, 
this confirms the diagnosis, but a normal echocar-
diogram does not rule out KD.1
As illustrated by this case, young infants are 
more likely than older children to present without 
the expected features of KD, putting them at 
greater risk of delayed diagnosis and associated 
sequelae.10
CaSe preSenTaTion
A 12-week-old Caucasian infant was admitted 
to hospital with a history of fever and vomiting. 
The illness had started 5 days earlier with diar-
rhoea and a non-specific rash on her abdomen 
and back.
No fevers were noted by the parents until the 
day of admission, on which she vomited and had a 
low-grade fever of 37.8°C, prompting her parents 
to bring her to the emergency department. There 
was no history of infectious contact. She had 
been born at 41+2 weeks gestation via ventouse 
delivery, had no previous medical problems and 
was up to date with immunisations.
Clinical examination on admission identified a 
high fever of 38°C, and a blanching erythematous 
rash over her whole body which resolved shortly 
after admission.
inveSTigaTionS
Admission blood results in her local hospital 
showed a normal white cell count of 11.7×109/L 
but an elevated CRP of 64 mg/L. Blood plate-
lets were high at 657×109/L and haemoglobin 
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was slightly low at 10.1 g/dL. Alanine transferase, bilirubin 
and albumin were normal.
Urine dip, viral screen and initial chest radiograph 
were all normal. Initial and repeat lumbar punctures were 
unremarkable.
The patient developed recurrent fevers over 38°C, which 
did not settle in spite of treatment for presumed bacterial 
sepsis with intravenous ceftriaxone. One set of blood cultures 
grew Moraxella osloensis, so a 3-day course of azithromycin 
was added, but this organism was subsequently felt likely to be 
a contaminant. There were no other positive microbiology or 
virology investigations.
There was no lymphadenopathy, joint problems or desqua-
mation of the extremities. Ultrasound examination of the 
abdomen and renal tract on day 11 of fever showed a grossly 
distended gallbladder. The same day an echocardiogram was 
performed, revealing a global pericardial effusion and aneu-
rysmal right and left coronary arteries.
The patient was transferred to a tertiary cardiology centre 
for management of presumed incomplete KD. The echocardio-
gram was repeated, confirming these findings, with a pericar-
dial effusion of 8 mm (figure 1), impaired myocardial function 
(fractional shortening 26%) and coronary artery Z-scores 
of +26 and +20.5 for the right (figure 2) and left (figure 3) coro-
nary arteries, respectively, indicative of giant coronary artery 
aneurysms. It was possible to visualise the dilated right coro-
nary artery, left anterior descending artery and circumflex artery 
down to the ventricular apex.
differenTial diagnoSiS
Prior to echocardiography:
 ► Bacterial sepsis
 ► Viral infections, such as enterovirus, adenovirus, norovirus
These more common childhood conditions present with 
similar non-specific features, such as fever and rash.
TreaTmenT
Intravenous immunoglobulin 2 g/kg (single dose) and high-
dose aspirin 7.5 mg/kg every 6 hours were started prior to 
transfer to the cardiology centre. Methylprednisolone (20 mg/
kg daily intravenously) and intravenous heparin (infusion 
titrated to achieve therapeutic anti-Xa levels) were initiated 
at the tertiary centre, and high-dose aspirin continued. The 
patient required a second dose of intravenous immunoglob-
ulin 5 days after the initial dose for recrudescence of fever. She 
received a blood transfusion for anaemia. She was discharged 
on low-dose aspirin (5 mg/kg daily), subcutaneous enoxaparin, 
a weaning dose of prednisolone and ranitidine.
ouTCome and follow-up
The patient was discharged 25 days after her initial presenta-
tion to hospital. Predischarge echocardiogram showed good 
biventricular function, reducing pericardial effusion and no 
evidence of coronary thrombus. ECG showed no evidence of 
ischaemia. CRP had peaked 11 days after the onset of fever at 
154 mg/L and fell to 7 mg/L 1 week after discharge. At clinic 
review 12 days after discharge, the patient was clinically well 
and gaining weight. Alongside regular clinical review, she is to 
be followed up with coronary angiography to document the 
full extent of coronary involvement.
diSCuSSion
The diagnostic challenge of this case stemmed largely from 
the fact that the patient, a Caucasian female infant aged just 
under 3 months, did not fit the typical KD patient profile. 
Only 1.6% of patients with recognised KD are younger 
than 3 months of age,11 and the disease is most common 
in Asian male children. Furthermore, our patient presented 
with incomplete KD, with fever and rash—signs that more 
figure 1 Pericardial effusion in short axis.
figure 2 Right coronary artery.
figure 3 Left coronary artery.
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commonly indicate viral infection in this age group—being 
the only features that fulfilled diagnostic criteria for KD. 
Nevertheless, she developed giant coronary aneurysms, 
demonstrating that the most severe sequelae can develop in 
patients with few of the typical symptoms. Abdominal ultra-
sound revealed hydrops of the gallbladder, also recognised as 
a manifestation of KD.12
Incomplete cases of KD present diagnostic difficulty for 
clinicians, particularly as echocardiography requires paediatric 
cardiology input. However, a 2013 survey found that 17% of 
UK district general hospitals that cared for children did not 
provide this service.13 In the present case, echocardiography 
was locally available and was instrumental in confirming the 
diagnosis of KD, highlighting the importance of having this 
service available to all children. We propose that echocardi-
ography should routinely be considered for any child with 
persistent unexplained fever, and particularly in children aged 
under 6 months, to try and prevent the sequelae of unrec-
ognised KD.
patient’s perspective
written by the patient’s mother and father
 ► Our daughter was 3 months old when she was admitted to 
hospital with sickness, diarrhoea and a high temperature. She 
had been unwell for 3–4 days by this stage but not admitted 
to hospital by her general practitioner as the illness was 
thought to be viral. There had been an initial rash but this 
disappeared after a few days in hospital.
 ► Initially she was treated for bacterial meningitis, then 
Moraxella and then herpes. Throughout her initial 10 days in 
hospital, she didn’t present many of the classic symptoms of 
Kawasaki apart from the regular spikes in temperature. While 
obviously unwell she seemed clinically fine which probably 
delayed the diagnosis of Kawasaki. Her symptoms seemed to 
suggest a viral infection however the ‘not knowing’ what she 
had was difficult as parents. 
 ► Throughout this time, we were worried that our daughter 
wasn’t getting any better and that her case was puzzling the 
doctors. On day 9  postadmission, the team were beginning 
to think outside the box and mentioned a rare disease called 
Kawasaki, although they didn’t think it was this. In hindsight 
this thinking outside the box may have saved her life. Once 
the echo was performed, the giant aneurysms in her coronary 
arteries were discovered and intravenous Ig was started 
within the hour and we were transferred to a specialist 
children’s hospital.
 ► Once the diagnosis was made, we felt the treatment and care 
was fantastic and our daughter is now doing as well as she 
can be. The first 48 hours postdiagnosis were the worst time 
in our lives.
 ► We will never know whether an earlier diagnosis would have 
stopped the aneurysms growing to the size they are; however, 
we are delighted that our daughter’s case is being published 
and hopefully the insight will help doctors ‘think Kawasaki’ 
earlier and diagnose cases to stop them developing into more 
serious Kawasaki cases.
learning points
 ► Kawasaki disease (KD) can affect children younger than 3 
months of age.
 ► Clinical suspicion is required to recognise KD in the youngest 
patients, as they are more likely to present with few features 
of KD.
 ► Consider KD in the differential diagnosis for any febrile infant 
who has no clear source of infection.
 ► Perform echocardiography where there is clinical suspicion of 
incomplete KD, but recognise that a normal echocardiogram 
does not exclude the diagnosis.
 ► Giant coronary artery aneurysms confer a significant risk of 
major adverse cardiac events. Early treatment with aspirin 
and intravenous immunoglobulin reduces the risk of these 
developing. Steroids are indicated in high-risk patients to 
minimise the progression of coronary artery lesions.
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